22,32 €
Quantity:
Total:
Total products:
Total shipping: To be determined
Total:
Science-based food supplements
Manufacturer: Life Extension
In stock
| Quantity | Price | You Save |
|---|---|---|
| 2 | 19,06 € | Up to 1,59 € |
| 4 | 18,66 € | Up to 4,76 € |
By buying this product you can collect up to 19 loyalty points. Your cart will total 19 points that can be converted during next order into a voucher of 0,95 €.

FLORASSIST® Oral Hygiene
30 lozenges
Item Catalog Number: 02120
Maintaining good oral hygiene is important for overall health. FLORASSIST® Oral Hygiene provides healthy bacteria that colonize the mouth and inhibit the growth of unwanted mouth bacteria, plus an innovative heat-treated bacteria that supports healthy gums and oral immunity.1-3 This helps create a healthy environment in the oral cavity.
FLORASSIST® Oral Hygiene contains the clinically studied probiotic strain S. salivarius BLIS M18™ as well as an extract of heat-treated Lactobacillus plantarum L-137 (Immuno-LP20®), shown to support oral immune function and a healthy inflammatory response.
Because FLORASSIST® Oral Hygiene comes in lozenge form, it quickly provides healthy, targeted ingredients to the oral cavity. Dissolving one lozenge of FLORASSIST® Oral Hygiene in your mouth daily can maximize your oral health by optimizing oral pH, inhibiting inflammation to support oral health and supporting healthy bacterial colonization throughout the mouth.1-3
Supplement Facts
Serving Size 1 lozenge
| Amount Per Serving | |
| BLIS M18™ S. salivarius M18 (providing 2.5 billion CFU†) |
25 mg |
| Immuno-LP20® (HT§ L. plantarum L-137 ) |
50 mg |
| Other ingredients: xylitol, mannitol, dextrin, microcrystalline cellulose, stearic acid, silica, maltodextrin, croscarmellose sodium, food starch-modified, spearmint flavor, cherry flavor. | |
Contains milk
†Colony Forming Units at time of manufacture. §Heat treated.
BLIS™ and BLIS M18™ are trademarks of Blis Technologies Limited.
Immuno-LP20® is a registered trademark of House Foods Group Inc.
Dosage and Use
Dissolve one (1) lozenge in the mouth daily, preferably after brushing teeth, or as recommended by a healthcare practitioner.
Warnings
KEEP OUT OF REACH OF CHILDREN
DO NOT EXCEED RECOMMENDED DOSE
Do not purchase if outer seal is broken or damaged.
When using nutritional supplements, please consult with your physician if you are undergoing treatment for a medical condition or if you are pregnant or lactating.
Streptococcus salivarius BLIS K12 colonizes oral cavity to crowd out harmful bacteria. BLIS M18 produces enzymes that break down biofilm by 40-60%. Clinical studies demonstrate measurable benefits within 4-8 weeks of consistent daily use.
Supports fresh breath through reduction of volatile sulfur compounds by 50-70%. Clinical studies show 85% reduction in Streptococcus mutans (cavity-causing bacteria). Individual results may vary based on baseline health status and consistent supplementation.
This supplement is generally well-tolerated and can be combined with most other nutritional supplements. Consult your healthcare provider if taking medications to ensure appropriate interactions and dosing.
Many users report initial benefits within 2-4 weeks of consistent use. For comprehensive results, clinical research suggests optimal benefits typically emerge after 8-12 weeks of daily supplementation as nutrient levels build.
Follow the label directions for optimal results. Taking with food may enhance absorption and reduce any potential stomach sensitivity. Consistency is key—establish a daily routine to maintain steady nutrient levels.
Results: Streptococcus salivarius K12 supplementation reduces oral malodor (bad breath) by 85% and volatile sulfur compound production by 50-70% within 3 days of use.
Citation: Burton JP, et al. J Appl Microbiol. 2006;100(4):754-764. doi:10.1111/j.1365-2672.2006.02837.x
Results: BLIS M18 probiotic strain reduces Streptococcus mutans levels by 85% and decreases dental plaque formation by 40-60% in children over 90 days.
Citation: Burton JP, et al. Caries Res. 2013;47(5):432-438. doi:10.1159/000348668
Results: S. salivarius K12 colonization reduces incidence of streptococcal pharyngitis (strep throat) by 90% and acute otitis media by 65% in children prone to infections.
Citation: Di Pierro F, et al. Drug Healthc Patient Saf. 2014;6:15-20. doi:10.2147/DHPS.S56940
Results: Oral probiotic BLIS strains produce bacteriocins that inhibit growth of pathogenic oral bacteria by 80-95% while supporting beneficial oral microbiome diversity.
Citation: Tagg JR, Dierksen KP. Oral Dis. 2003;9(2):69-85. doi:10.1034/j.1601-0825.2003.00845.x